BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.39 CHF | -0.25% |
|
-18.16% | -18.16% |
| 09:14pm | Bristol-Myers Squibb's Colorectal Cancer Therapy Receives FDA Approval | MT |
| 07:27pm | US FDA approves Bristol Myers' colorectal cancer therapy | RE |
Quotes 5-day view
Delayed Quote Swiss Exchange| 17/06/2024 | 18/06/2024 | 19/06/2024 | 20/06/2024 | |
|---|---|---|---|---|
| Last | 54.24 CHF | 54.24 CHF | 54.24 CHF | 54.24 CHF |
| Change | -.--% | -.--% | -.--% | -.--% |
Performance
| 1 day | -0.25% | ||
| 1 week | -18.16% | ||
| Current month | -18.16% | ||
| 1 month | -18.16% | ||
| 3 months | -18.16% | ||
| 6 months | -18.16% | ||
| Current year | -18.16% | ||
| 1 year | -18.16% | ||
| 5 years | -6.74% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CHF)
83 192 187 939
Capitalization (USD)
83 192 187 939
Net sales (USD)
45 006 000 000
Number of employees
34 100
Sales / Employee (USD)
1 319 824
Free-Float
69.27 %
Free-Float capitalization (CHF)
92 928 968 102
Free-Float capitalization (USD)
83 102 659 015
Highs and lows
1 week
44.39
54.24
1 month
44.3954.24
Current year
44.3954.24
1 year
44.3954.24
3 years
44.3954.24
5 years
44.3954.24
10 years
44.3974.80
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.25% | -18.16% | -18.16% | -18.16% | 8.32TCr | ||
| -0.24% | +0.62% | +51.63% | +95.12% | 80TCr | ||
| -0.59% | -0.31% | +41.51% | +80.74% | 63TCr | ||
| +0.66% | +2.21% | -5.10% | -9.23% | 36TCr | ||
| +0.81% | +0.96% | +19.90% | +17.60% | 33TCr | ||
| -1.01% | +1.07% | +9.95% | +24.50% | 30TCr | ||
| +0.60% | -0.30% | +17.66% | +7.65% | 24TCr | ||
| +1.12% | +2.10% | +3.39% | -7.69% | 23TCr | ||
| -0.36% | -1.07% | +10.75% | +3.83% | 22TCr | ||
| -0.56% | +3.19% | +6.99% | +35.73% | 17TCr | ||
| 0.00% | +0.76% | -3.65% | -28.69% | 16TCr | ||
| -0.56% | +1.38% | -2.38% | -10.62% | 12TCr | ||
| +3.18% | +8.62% | -12.76% | -8.94% | 8.53TCr | ||
| -1.17% | -0.34% | +10.26% | +16.56% | 8.36TCr | ||
| -0.26% | -2.59% | +40.75% | +15.05% | 6.58TCr | ||
| -.--% | +1.73% | - | - | 6.37TCr | ||
| Average | +0.08% | +1.38% | +11.38% | +14.23% | ||
| Weighted average by Cap. | +0.05% | +1.20% | +21.70% | +35.75% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -.--% | ||
| 2023 | -.--% | ||
| 2022 | -.--% | ||
| 2021 | +22.19% | ||
| 2020 | -.--% | ||
| 2019 | -10.31% | ||
| 2018 | -17.52% | ||
| 2017 | -0.25% | ||
| 2016 | -12.76% | ||
| 2015 | +17.46% | ||
| 2014 | +7.41% |
- Stock Market
- Equities
- BMY Stock
- BMY Stock
- Quotes Bristol-Myers Squibb Company
